Northern Trust’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$862K Sell
82,944
-9,393
-10% -$97.6K ﹤0.01% 3457
2025
Q1
$1.22M Sell
92,337
-2,693
-3% -$35.5K ﹤0.01% 3195
2024
Q4
$1.7M Buy
95,030
+31,915
+51% +$572K ﹤0.01% 3116
2024
Q3
$1.02M Buy
63,115
+32,191
+104% +$519K ﹤0.01% 3349
2024
Q2
$835K Sell
30,924
-258
-0.8% -$6.97K ﹤0.01% 3320
2024
Q1
$608K Sell
31,182
-341
-1% -$6.65K ﹤0.01% 3497
2023
Q4
$652K Sell
31,523
-55
-0.2% -$1.14K ﹤0.01% 3455
2023
Q3
$1M Buy
31,578
+471
+2% +$15K ﹤0.01% 3298
2023
Q2
$1.05M Buy
31,107
+24,159
+348% +$812K ﹤0.01% 3346
2023
Q1
$290K Sell
6,948
-169
-2% -$7.05K ﹤0.01% 3681
2022
Q4
$241K Hold
7,117
﹤0.01% 3782
2022
Q3
$350K Buy
7,117
+491
+7% +$24.1K ﹤0.01% 3628
2022
Q2
$260K Sell
6,626
-19,394
-75% -$761K ﹤0.01% 3784
2022
Q1
$960K Sell
26,020
-1,480
-5% -$54.6K ﹤0.01% 3431
2021
Q4
$2.69M Sell
27,500
-671
-2% -$65.6K ﹤0.01% 3068
2021
Q3
$3.52M Buy
28,171
+7,907
+39% +$987K ﹤0.01% 2957
2021
Q2
$2.54M Sell
20,264
-4,185
-17% -$525K ﹤0.01% 3247
2021
Q1
$3.32M Sell
24,449
-2,181
-8% -$296K ﹤0.01% 2993
2020
Q4
$2.42M Sell
26,630
-276
-1% -$25.1K ﹤0.01% 3099
2020
Q3
$2M Buy
26,906
+21,711
+418% +$1.62M ﹤0.01% 3059
2020
Q2
$443K Buy
5,195
+2,435
+88% +$208K ﹤0.01% 3586
2020
Q1
$199K Sell
2,760
-56
-2% -$4.04K ﹤0.01% 3686
2019
Q4
$201K Buy
2,816
+198
+8% +$14.1K ﹤0.01% 3797
2019
Q3
$137K Sell
2,618
-10,019
-79% -$524K ﹤0.01% 3855
2019
Q2
$678K Sell
12,637
-1,368
-10% -$73.4K ﹤0.01% 3474
2019
Q1
$995K Buy
14,005
+6,851
+96% +$487K ﹤0.01% 3358
2018
Q4
$572K Buy
7,154
+7
+0.1% +$560 ﹤0.01% 3522
2018
Q3
$3.33M Buy
7,147
+1,923
+37% +$897K ﹤0.01% 2931
2018
Q2
$2.08M Buy
5,224
+554
+12% +$220K ﹤0.01% 3192
2018
Q1
$1.43M Buy
4,670
+54
+1% +$16.5K ﹤0.01% 3268
2017
Q4
$1.36M Sell
4,616
-62
-1% -$18.3K ﹤0.01% 3306
2017
Q3
$2.56M Buy
4,678
+645
+16% +$353K ﹤0.01% 3031
2017
Q2
$2.4M Buy
4,033
+2,717
+206% +$1.62M ﹤0.01% 3068
2017
Q1
$566K Buy
1,316
+84
+7% +$36.1K ﹤0.01% 3498
2016
Q4
$634K Buy
+1,232
New +$634K ﹤0.01% 3471